DNA Technology: Enterofloor Children (Rapid tests for diagnosing children's intestines)

Main article: Intestines

2023: Production launch

The capital company has launched the production of medical tests that allow diagnosing the intestinal microbiota of children in three hours, Deputy Mayor of Moscow for Economic Policy and Property and Land Relations Vladimir Efimov said on February 15, 2023.

As of February 2023, more than 200 enterprises of the capital specialize in the production of medicines and medical devices, offer both standard and innovative drugs and solutions for the treatment and diagnosis of various diseases. The city's companies continue to expand product lines with products, some of them have no analogues in the world. For example, the metropolitan enterprise DNA-Technology developed, patented and began mass production of tests to determine the quantitative assessment of the gut microbiota of children under 14 years old based on the PCR method. They can be used by doctors of various specialties, including pediatricians, gastroenterologists and allergists, - said Vladimir Efimov.

The advantage of this development is the correct result for all the main types of microorganisms that make up the microbiota of the infant intestine, including difficult-to-cultivate bacteria.

{{quote 'The test allows you to determine the intestinal health of the child in a short period of time by 43 basic indicators, which is up to 99.9 percent of microflora. Every year the company plans to produce over 15 thousand sets of reagents. The first batches have already gone on sale, - said Vladislav Ovchinsky, head of the Moscow Department of Investment and Industrial Policy. }}

The use of the molecular genetic method avoided the stringent requirements for the collection, storage and transportation of biomaterial. This is important for the organization of testing in clinics and medical laboratories.

According to Vladimir Colin, Director General of DNA Technology, the use of the ENTEROFLOR Children test opens up additional opportunities for the prevention, early diagnosis and treatment of patients under 14 years old, since the composition of the intestinal microbiota is an integral part of assessing the general state of the child's body.